Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
Clinical trial NCT04972656 · UNKNOWN
Trial details
- NCT number
- NCT04972656
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-05
- Primary completion
- 2025-12-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.